Anterra Capital

Invetx Inc., a pioneer in protein-based therapeutics for animal health, announced today that it has agreed to be acquired by Dechra Pharmaceuticals Limited (Dechra), a global specialist veterinary pharmaceuticals business, for up to $520 million in total consideration on a cash-free and debt-free basis. Phil Austin, managing partner and co-founder of Anterra Capital, stated “The exit of Invetx is an exceptional outcome not only for the stakeholders in the company but also for the broader start-up community and the animal health industry. Invetx is a great example of how start-ups can drive innovation in this industry. We are excited to see the Invetx products come to market and support Dechra in its ambitious growth plans.”

Vestaron Receives EPA Approval for Second Active Ingredient: BASIN® Bioinsecticide We are thrilled to announce the Environmental Protection Agency (EPA) has approved our second novel-acting peptide-based insecticide, BASIN®. This approval marks a significant milestone in Vestaron's mission to revolutionize the agricultural crop protection industry by creating the novel modes of action growers need to effectively manage pests while enhancing sustainability. BASIN represents a breakthrough insecticide developed through the company’s world-class research and development platform, controlling a wide range of crop-damaging pests and providing MRL exemption for ultimate marketing flexibility. Read more: https://lnkd.in/eWB9-cbp #SustainableAgriculture #CropProtection #Innovation #AgTech

New weight loss drugs - so-called GLP-1s – are taking the world by storm. Will they beat the obesity epidemic or just help celebrities fit in Versace dresses? Will GLP-1s spell doom for healthy diets or force Big Food to stop pushing junk calories? My gut tells me this is the start of a weight-loss revolution with huge net positive effects for human health.   “Body not by Ozempic,” joked actress Christina Applegate at the Emmy Awards ceremony, mocking Hollywood’s get-even-skinnier-fast trend by taking Ozempic, the weight loss drug by Danish pharmaceutical company Novo Nordisk. And it’s true: since the drug costs $1000 a month and most insurance companies don’t cover it for weight loss (it’s officially a diabetes drug), Ozempic is disproportionately used by the rich for that purpose.    It’s clear, however, that investors expect that GLP-1s will soon be widely used to combat the global obesity crisis. The value of Novo Nordisk now exceeds the annual GDP of its home country, Denmark, mainly driven by enthusiasm about Ozempic's weight-loss properties.     Investors bet insurance companies will ultimately embrace weight loss as a legitimate use for GLP-1 drugs and reimburse their obese patients. Asset manager Amundi predicts that by 2030, 150 million people in the US and Europe will be insured to use GLP-1s to lose weight. Soon after that, the first GLP-1 patents will expire, opening the door for cheap generic alternatives.    Insurance companies would broaden eligibility for good reason: global obesity levels keep rising -  now 1 billion people worldwide – and evidence that obesity is a major health risk – from cardiovascular diseases to severe complications from viruses like Covid – is piling up.    But don’t weight loss drugs just battle the symptoms of obesity, not its root cause, as some people claim? They suppress your appetite, but when you stop taking them, your appetite comes back. So you're stuck with the drugs for life, including their potential side effects, like nausea, fatigue, and more severe stomach and kidney issues.    However, early evidence suggests (see first comment) that patients taking weight loss drugs also switch to healthier diets and exercise routines, even after they stop. That is great news for food companies focusing on healthy foods, including companion products for the millions of people on GPL-1s. But it’s bad news for Big Food, which makes a lot of money stuffing supermarket shelves with processed food items that undermine our health.    Large food companies downplay the risk, saying the drugs may slightly lower the demand for junk food but not enough to structurally push them in a healthier direction. Of course, that’s what retail chains initially said about online shopping and car companies about EVs. I believe GLP-1s will trigger an earthquake, and processed foods will hopefully be right over the faultline.   bit.ly/3SuV86f #4thFoodrevolution #glp1 #obesity #diet #junkfood #healthandwellness #ozempic

🌍🚀 Win €25,000 to boost your startup's impact with the 𝐅𝐞𝐢𝐤𝐞 𝐒𝐢𝐣𝐛𝐞𝐬𝐦𝐚 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐀𝐰𝐚𝐫𝐝 🌟 Are you an entrepreneur with a groundbreaking vision for a sustainable, climate-resilient agrifood system? We have something exciting for you! The Feike Sijbesma Sustainable Innovation Award, a prestigious recognition for innovative entrepreneurs who are reshaping the future of global agrifood systems, is now integrated with the ‘𝐍𝐞𝐱𝐭 𝐇𝐞𝐫𝐨𝐞𝐬 𝐢𝐧 𝐅𝐨𝐨𝐝 & 𝐀𝐠𝐭𝐞𝐜𝐡’ by F&A Next. 𝐈𝐟 𝐲𝐨𝐮 𝐚𝐫𝐞 𝐬𝐞𝐥𝐞𝐜𝐭𝐞𝐝 𝐚𝐬 𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 10 ‘𝐍𝐞𝐱𝐭 𝐇𝐞𝐫𝐨𝐞𝐬 𝐢𝐧 𝐅𝐨𝐨𝐝 & 𝐀𝐠𝐭𝐞𝐜𝐡’, 𝐲𝐨𝐮 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐜𝐚𝐥𝐥𝐲 𝐞𝐧𝐭𝐞𝐫 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐅𝐞𝐢𝐤𝐞 𝐒𝐢𝐣𝐛𝐞𝐬𝐦𝐚 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐥𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐀𝐰𝐚𝐫𝐝. Apply if your startup is: 💡 working on a truly innovative and sustainable product or technology with an application in food and/or agriculture 🌍 aiming for impact at scale with a focus on sustainability (people, profit and planet) and climate resilient agrifood systems 🚀 on track or building a successful business and building something that consumers or the industry needs / wants ✅ anywhere from Pre-seed to Series-B stage. (Startup is not older than 10 years) 🤝  actively looking for funding or partnerships This award, named in honor of Feike Sijbesma (former DSM CEO), who is renowned for making a significant impact with sustainable innovations in his capacity as a global corporate leader, is empowered by DSM Brighter Living Foundation to promote science-based solutions from innovative startups around the world. If you have what it takes to be a Next Hero in Food & Agtech, we'd love to hear from you! More info and apply 👇 https://lnkd.in/dRBHkGuZ #FANext2024 #SustainableInnovation #ClimateChange #FoodSystems #Agritech #Foodtech  University Fund Wageningen

🤔Are you a startup in the AgriFoodTech space looking to transform the food system of tomorrow? 💪StartLife is here to help you achieve your goals! Our team is on the hunt for the most innovative AgriFoodTech startups today, and we want you to join our next Accelerate cohort. 🌱We understand the urgency to innovate and feed the planet while taking care of it. If you're up for the challenge, we invite you to apply now! 🚀Our Accelerate program is designed to help you find product-market fit, connect with the FoodValley ecosystem, and explore funding opportunities to take your business to the next level. 💚Don't miss out on this opportunity to grow your startup and make a positive impact on the world. Apply before 19 January and let's team up to create a better future for all 👇 🔗https://lnkd.in/e6SiZhbg #agrifoodtech #startlifeaccelerate #startupgrowth #innovation #sustainability #futureoffood #foodsystemtransformation 

🚀 Calling All Food & AgTech Innovators! 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐍𝐞𝐱𝐭 𝐇𝐞𝐫𝐨𝐞𝐬 𝐢𝐧 𝐅𝐨𝐨𝐝 & 𝐀𝐠𝐓𝐞𝐜𝐡 𝐢𝐬 𝐍𝐨𝐰 𝐎𝐩𝐞𝐧 🌱 Is your startup making big changes in food and agriculture? F&A Next is offering 10 amazing agrifoodtech startups a unique chance to shine on stage at our event. This is a big deal! Our audience is full of important people from all over the world, including lots of investors, big companies, and the media. Don’t miss out on showing the world what your startup can do! Pitch Your StartUp to world’s leading Agrifoodtech Investors & Corporates 🌟🌍 More info here 👇 https://lnkd.in/ekWtPURU Apply before the 29th of February at 23:59 Central European Time (CET) here👇 https://lnkd.in/egEpza7T Organizing partners: Wageningen University & Research, Rabobank, StartLife, Anterra Capital, Foodvalley NL #fanext #fanext2024 #agrifoodtech #agtech #foodtech #nextheroes

It was exactly ten years ago that we launched Anterra in Amsterdam. When we started, nobody even bothered to measure the agrifoodtech market size. Now, annual investments are $30 billion per year. Our ever-growing community of entrepreneurs, investors, farmers, and food companies is giving their all to create a healthier, more resilient, and more sustainable food system. So, what did our ten-year rollercoaster ride look like? The world changed a lot. Food security moved from a thought to a priority. The realization has sunk in that food contributes to more than 25% of carbon emissions while simultaneously fuelling a global obesity pandemic. We collected battle scars along the way, but seeing our family of companies making a difference in global food, it’s been worth it. ProducePay helped Latin American fresh produce growers send plus $3 billion of produce to the US last year; our first incubated company, Enko®, developed a potential “best in class” herbicide that could reduce RoundUp usage by 95%, and Jennifer Doudna did her Nobel prize-winning work with Caribou Biosciences. It feels like a breach of trust to name just a few of the entrepreneurs we have backed in our first decade. Without their brilliance and drive, Anterra would be an empty vessel, so our congratulations to the teams behind Agriconomie.com, 5Metis, Inc., Animol Discovery, Inc., Ashish Life Science , Berkeley Yeast, BiomEdit, Dalma., Edge animal health, Farmobile, Invetx, It's Fresh!, Kate Farms LLC, La Fourche, Lollipop, Native Microbials, Inc., Orogen Therapeutics, Slingshot Biosciences, Smartwyre, Vestaron Corporation, Zebi AI. Then, the Anterra team, whose dedication identified, incubated, and grew our portfolio companies. They are the most brilliant, motivated, and fun people I’ve worked with (Philip Austin, Maarten Goossens, Anneke Stelte, Neira Pekmez, Yorán Meijers, Brett Wong, Brett Chevalier, Michael Widmann, and Michael Topalian).   Through the years, Anterra transformed itself from investor to investor and incubator, building 6 successful companies from scratch, with our limited partners co-investing alongside us; for every dollar we put in our portfolio companies, they have added two more. Our dream to accelerate the transformation of the food system would not have been possible without the initial support of Rabobank and Eight Roads, followed by many value-adding investors, including, Tattarang, Temasek, Novo Holdings, LGT Wealth Management, the UK EAPF.     Last but not least, I want to mention the F&A Next conference that Anterra co-founded with Rabobank, StartLife and Wageningen University & Research. It is heartening to see that it has developed into the premier European agrifood-tech conference.    A big thank you to all of you who made Anterra’s first ten years a success.    P.S.: To celebrate Anterra’s anniversary, we’ve treated ourselves to a new website. So, have a peek. #4thFoodRevolution, #Anterra, #agtech, #foodsecurity